{"id":"https://openalex.org/W2007384961","doi":"https://doi.org/10.1136/ard.58.2008.i129","title":"Access to disease modifying treatments for rheumatoid arthritis patients","display_name":"Access to disease modifying treatments for rheumatoid arthritis patients","publication_year":1999,"publication_date":"1999-11-01","ids":{"openalex":"https://openalex.org/W2007384961","doi":"https://doi.org/10.1136/ard.58.2008.i129","mag":"2007384961","pmid":"https://pubmed.ncbi.nlm.nih.gov/10577989","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1766569"},"language":"en","primary_location":{"id":"doi:10.1136/ard.58.2008.i129","doi":"https://doi.org/10.1136/ard.58.2008.i129","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.58.2008.i129","pdf_url":"https://ard.bmj.com/content/annrheumdis/58/suppl_1/I129.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/58/suppl_1/I129.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052078671","display_name":"Daniel E. F\u00fcrst","orcid":"https://orcid.org/0000-0002-4018-7629","observed_orcids":["https://orcid.org/0000-0002-4018-7629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D E FURST","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111692713","display_name":"Ferry C Breedveld","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F C BREEDVELD","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076851275","display_name":"Gerd R\u00fcdiger Burmester","orcid":"https://orcid.org/0000-0001-7518-1131","observed_orcids":["https://orcid.org/0000-0001-7518-1131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G-R BURMESTER","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069490679","display_name":"Leslie J. Crofford","orcid":"https://orcid.org/0000-0002-6347-5738","observed_orcids":["https://orcid.org/0000-0002-6347-5738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L CROFFORD","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018678002","display_name":"Paul Emery","orcid":"https://orcid.org/0000-0002-7429-8482","observed_orcids":["https://orcid.org/0000-0002-7429-8482","https://orcid.org/0000-0002-4136-3436"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P EMERY","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068474438","display_name":"Marc Allan Feldman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M FELDMAN","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111538700","display_name":"Joachim Robert Kalden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J R KALDEN","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107413697","display_name":"Arthur Kavanaugh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A KAVANAUGH","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080646462","display_name":"Edward Clark Keystone","orcid":"https://orcid.org/0000-0001-6606-0071","observed_orcids":["https://orcid.org/0000-0001-6606-0071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E KEYSTONE","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043874873","display_name":"Peter E. Lipsky","orcid":"https://orcid.org/0000-0002-9287-1676","observed_orcids":["https://orcid.org/0000-0002-9287-1676"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P E LIPSKY","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111772241","display_name":"Ravinder Nath Maini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R N MAINI","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066780563","display_name":"Larry W. Moreland","orcid":"https://orcid.org/0000-0003-4483-0359","observed_orcids":["https://orcid.org/0000-0003-4483-0359"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L MORELAND","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090753435","display_name":"Josef S Smolen","orcid":"https://orcid.org/0000-0002-4302-8877","observed_orcids":["https://orcid.org/0000-0002-4302-8877"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J S SMOLEN","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042219534","display_name":"LB Van de Putte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L VAN DE PUTTE","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109807086","display_name":"THOMAS L VISCHER","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T VISCHER","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047117557","display_name":"Michael E. Weinblatt","orcid":"https://orcid.org/0000-0001-5215-5512","observed_orcids":["https://orcid.org/0000-0001-5215-5512"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M WEINBLATT","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008134404","display_name":"Myrna M. Weissman","orcid":"https://orcid.org/0000-0003-3490-3075","observed_orcids":["https://orcid.org/0000-0003-3490-3075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M WEISSMAN","raw_affiliation_strings":["representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"representing the approximately 80 rheumatologists at the Advances in Targeted Therapies TNF Blockade in Clinical Practice","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":2.796,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.89774532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"58","issue":null,"first_page":"I129","last_page":"I130"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":1.0},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.9869999885559082},{"id":"https://openalex.org/keywords/access-to-treatment","display_name":"access to treatment","score":0.824999988079071},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5899999737739563},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.453000009059906},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.609000027179718},{"id":"https://openalex.org/keywords/treatment-supervision","display_name":"treatment supervision","score":0.40700000524520874},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.7250000238418579},{"id":"https://openalex.org/keywords/acute-phase-proteins","display_name":"acute phase proteins","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9606183767318726},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8170377612113953},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.44333893060684204},{"id":"https://openalex.org/C2779123688","wikidata":"https://www.wikidata.org/wiki/Q421094","display_name":"Hydroxychloroquine","level":5,"score":0.41130828857421875},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38879433274269104},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3594311475753784},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34497252106666565},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3397985100746155},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3159496784210205},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.09821122884750366},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.07430389523506165}],"mesh":[{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/ard.58.2008.i129","doi":"https://doi.org/10.1136/ard.58.2008.i129","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.58.2008.i129","pdf_url":"https://ard.bmj.com/content/annrheumdis/58/suppl_1/I129.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:414123","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1766569","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:10577989","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10577989","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Consensus Statement"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:58/suppl_1/I129","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/58/suppl_1/I129","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/ard.58.2008.i129","doi":"https://doi.org/10.1136/ard.58.2008.i129","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.58.2008.i129","pdf_url":"https://ard.bmj.com/content/annrheumdis/58/suppl_1/I129.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7799999713897705}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2007384961.pdf","grobid_xml":"https://content.openalex.org/works/W2007384961.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1971791896","https://openalex.org/W1983145703","https://openalex.org/W1996472975","https://openalex.org/W1997464096","https://openalex.org/W2004979148","https://openalex.org/W2011700185","https://openalex.org/W2039499980","https://openalex.org/W2043287930","https://openalex.org/W2059275164","https://openalex.org/W2059459516","https://openalex.org/W2089451949","https://openalex.org/W2142273705","https://openalex.org/W2156755388","https://openalex.org/W2314052274","https://openalex.org/W2328587823"],"related_works":["https://openalex.org/W2167795312","https://openalex.org/W2046730711","https://openalex.org/W2049814117","https://openalex.org/W2151207112","https://openalex.org/W1975615929","https://openalex.org/W2100285949","https://openalex.org/W2397124945","https://openalex.org/W1969921902","https://openalex.org/W2571087993","https://openalex.org/W6999836386"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}